Recent Finacing
Recent Raise
Exavir Therapeutics is a preclinical-stage biotechnology company developing modality-agnostic, long-acting antiviral therapeutics aimed at eliminating HIV and other viral infections.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors